| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K51831558 |
| PharmacoGx | BRD-K51831558 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDPK1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | RAPGEF1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | OR10R2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | DNAI2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | SCN4A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | ARID3A | CTRPv2 | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | CTAG1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | CAMSAP1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | PRDM1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | RP11-211G3.2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
